Multi-center Clinical Study on Neonatal Hyperbilirubinemia

NCT03824990 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20000

Last updated 2021-11-01

No results posted yet for this study

Summary

Eight hospitals in China will participate in the study, which aims to decrease the incidence of severe hyperbilirubinemia.

Conditions

  • Quality Improvement
  • Hyperbilirubinemia, Neonatal

Interventions

BEHAVIORAL

Quality improvement of management of neonatal jaundice

During the Intervention phase and Sustainability phase ,The hospitals will receive training of multiple evidence based quality improvement methods.

Sponsors & Collaborators

  • JiLin Women and Children Health Hospital

    collaborator UNKNOWN
  • Shandong Provincial Hospital

    collaborator OTHER_GOV
  • Shan Dong Qian Fo Shan Hospital

    collaborator UNKNOWN
  • Shan Dong Liao Cheng Hospital

    collaborator UNKNOWN
  • Guangxi Maternal and Child Health Hospital

    collaborator OTHER
  • Northwest Women's and Children's Hospital, Xi'an, Shaanxi

    collaborator OTHER
  • Yin Chuan Maternity and Child Health Hospital

    collaborator UNKNOWN
  • Nanjing Medical University

    lead OTHER

Principal Investigators

  • Shuping Han, PHD · Nanjing Maternity and Child Health Care Hospital

  • Zhangbin Yu, PHD · Nanjing Maternity and Child Health Care Hospital

  • Zhiyong Sun, PHD · JiLin Women and Children Health Hospital

  • Haiyan Cai, PHD · Qinhuangdao Maternal and Child Health Care Hospital

  • Yonghui Yu, MD · Shandong Provincial Hospital

  • Xin Yuan, MD · Shan Dong Qian Fo Shan Hospital

  • Jin Qian, MD · Shan Dong Liao Cheng Hospital

  • Jimei Wang, PHD · Obstetrics & Gynecology Hospital of Fudan University

  • Wenyan Tang, PHD · Jiangxi Maternal and Child Health Hospital

  • Qiufen Wei, PHD · Guangxi Maternal and Child Health Hospital

  • Zhankui Li, PHD · Northwest Women's and Children's Hospital, Xi'an, Shaanxi

  • Jie Gu, PHD · Yin Chuan Maternity and Child Health Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
28 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2021-08-31
Completion
2021-10-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03824990 on ClinicalTrials.gov